[go: up one dir, main page]

ES2036174T3 - Un procedimiento para la preparacion de una combinacion broncodilatadora de prazosin-pirbuterol. - Google Patents

Un procedimiento para la preparacion de una combinacion broncodilatadora de prazosin-pirbuterol.

Info

Publication number
ES2036174T3
ES2036174T3 ES198686308544T ES86308544T ES2036174T3 ES 2036174 T3 ES2036174 T3 ES 2036174T3 ES 198686308544 T ES198686308544 T ES 198686308544T ES 86308544 T ES86308544 T ES 86308544T ES 2036174 T3 ES2036174 T3 ES 2036174T3
Authority
ES
Spain
Prior art keywords
pirbuterol
prazosin
procedure
preparation
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198686308544T
Other languages
English (en)
Inventor
Craig Allan Paul Dance Saxton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp SRL
Original Assignee
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp SRL filed Critical Pfizer Corp SRL
Application granted granted Critical
Publication of ES2036174T3 publication Critical patent/ES2036174T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPRENDE UN PORTADOR FARMACEUTICAMENTE ACEPTABLE Y UN BRONCODILATADOR EFECTIVO A PARTIR DE UNA MEZCLA DE 10 A 90 PARTES EN PESO DE BRAZOSIN O LA SAL O EL ACIDO FARMACEUTICAMENTE ACEPTABLES DE LA ADICION DEL ACIDO, Y DE 90 A 10 PARTES POR PESO DE PIRBUTEROL O LA SAL CONSECUENTE DE UN ACIDO FARMACEUTICAMENTE ACEPTABLE. TIENE UTILIDAD EN MEDICINA COMO REBAJADOR DE LOS TEJIDOS BRONQUIALES EN LOS MAMIFEROS, ESPECIALMENTE PARA EL TRATAMIENTO DE LAS BRONCOCONSTRICCIONES.
ES198686308544T 1985-11-06 1986-11-03 Un procedimiento para la preparacion de una combinacion broncodilatadora de prazosin-pirbuterol. Expired - Lifetime ES2036174T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/795,689 US4601897A (en) 1985-11-06 1985-11-06 Prazosin-pirbuterol combination for bronchodilation

Publications (1)

Publication Number Publication Date
ES2036174T3 true ES2036174T3 (es) 1993-05-16

Family

ID=25166193

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198686308544T Expired - Lifetime ES2036174T3 (es) 1985-11-06 1986-11-03 Un procedimiento para la preparacion de una combinacion broncodilatadora de prazosin-pirbuterol.

Country Status (14)

Country Link
US (1) US4601897A (es)
EP (1) EP0222575B1 (es)
JP (1) JPS62135424A (es)
AT (1) ATE59295T1 (es)
AU (1) AU567018B2 (es)
CA (1) CA1284107C (es)
DE (1) DE3676640D1 (es)
DK (1) DK527186A (es)
ES (1) ES2036174T3 (es)
GR (1) GR3001420T3 (es)
IE (1) IE59327B1 (es)
IL (1) IL80476A0 (es)
NZ (1) NZ218175A (es)
ZA (1) ZA868427B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868182A (en) * 1986-11-05 1989-09-19 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
ZA878182B (en) * 1986-11-05 1988-05-02 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
US5110927A (en) * 1987-12-31 1992-05-05 The United States Of America As Represented By The Department Of Health And Human Services Prazosin analog with increased selectivity and duration of action
US5766573A (en) * 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US6048857A (en) * 1989-10-17 2000-04-11 Ellinwood, Jr.; Everett H. Dosing method of administering medicaments via inhalation administration
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
JP2008535924A (ja) 2005-04-12 2008-09-04 エラン ファーマ インターナショナル リミテッド ナノ粒子キナゾリン誘導体製剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3723434A (en) * 1970-07-17 1973-03-27 Pfizer Piperazino isoquinoline bronchodilators
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
US3786160A (en) * 1971-02-16 1974-01-15 Pfizer Use of 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)-pyridines as bronchodilators
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
US4175128A (en) * 1979-01-03 1979-11-20 Pfizer Inc. Method for treating congestive heart failure
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
DE3235565A1 (de) * 1982-09-25 1984-03-29 Boehringer Ingelheim KG, 6507 Ingelheim Piperidinderivate, ihre herstellung und verwendung

Also Published As

Publication number Publication date
ZA868427B (en) 1988-06-29
GR3001420T3 (en) 1992-09-25
JPH0524890B2 (es) 1993-04-09
CA1284107C (en) 1991-05-14
IE59327B1 (en) 1994-02-09
NZ218175A (en) 1989-04-26
IL80476A0 (en) 1987-02-27
DE3676640D1 (de) 1991-02-07
IE862911L (en) 1987-05-06
EP0222575B1 (en) 1990-12-27
AU6483286A (en) 1987-05-21
ATE59295T1 (de) 1991-01-15
EP0222575A1 (en) 1987-05-20
DK527186A (da) 1987-05-07
JPS62135424A (ja) 1987-06-18
DK527186D0 (da) 1986-11-05
AU567018B2 (en) 1987-11-05
US4601897A (en) 1986-07-22

Similar Documents

Publication Publication Date Title
PT82580B (pt) Processo para a preparacao de 2',3'- didesoxinucleosidos e de composicoes farmaceuticas que os contem
ES520988A0 (es) Procedimiento para la preparacion de nuevos 6,11-dihidro-dibenzo-(b,e)-tiepin-11-n-alcohilnorescopin-eteres.
CY1112139T1 (el) Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
ES2036737T3 (es) Procedimiento para la obtencion de mezclas farmaceuticas.
ES510087A0 (es) Procedimiento para la preparacion de nuevos compuestos de aorilimidazol-2-ona.
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
DE69802113D1 (de) Zusammensetzungen zur erhöhung der konzentration und/oder beweglichkeit von samenzellen in menschen
ATE201880T1 (de) Oberflächenaktive zusammensetzungen und verfahren
ES2036174T3 (es) Un procedimiento para la preparacion de una combinacion broncodilatadora de prazosin-pirbuterol.
ES8609312A1 (es) Procedimiento para la preparacion de silibinina exenta de isosilibina
ES507807A0 (es) Procedimiento para la obtencion de derivados triciclicos de citosina.
AU611113B2 (en) Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds
DE3361990D1 (en) Alkylene-bridged guanidino-thiazole derivatives, method for their preparation and their use as medicaments
MX170706B (es) Procedimiento para la preparacion de (-) -n"ciano-n-3- piridil -n'- 1, 2, 2-trimetilpropilguanidina
ES495826A0 (es) Procedimiento para la obtencion de acido fosfonohidroxiace- tico
IT1197516B (it) Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
ES552948A0 (es) Un procedimiento para la preparacion de nuevos compuestos poliprenilicos.
IT8319219A0 (it) Derivati di arilossipropanolamina, procedimento per la loro preparazione composizioni farmaceutiche cheli contengono e loro impiego terapeutico
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
ES2022501B3 (es) Procedimiento para preparar un aducto de lactato calcico y glicerol, y su empleo.
ES2120966T3 (es) 1'-aminoespiro(isoquinolino-4(1h),3'-pirrolidino)-1,2',3,5'(2h)-tetronas y analogos de las mismas utiles como inhibidores de la aldosa reductasa in vivo.
ES2038139T3 (es) Combinacion de substancias activas que contienen diltiazem y acido acetilsalicilico, su obtencion asi como su empleo para la fabricacion de medicamentos con un efecto inhibidor de la agregacion de trombocitos.
PT97052A (pt) Processo para a preparacao de composicoes farmaceuticas contendo bambuterol, apropriadas para diminuir o teor de lipidos no sangue
IT8747852A0 (it) Benzammidi sostituite, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
ES2059442T3 (es) Uso de gepirona para la preparacion de composiciones farmaceuticas para mitigar alteraciones de panico.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 222575

Country of ref document: ES